|
CASC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9190999994988E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.299400E-03 |
| Normal-vs-Stage2 |
9.661900000002E-05 |
| Normal-vs-Stage3 |
6.09460004685758E-09 |
| Normal-vs-Stage4 |
6.18429973897605E-10 |
| Stage1-vs-Stage2 |
6.235600E-02 |
| Stage1-vs-Stage3 |
1.241790E-04 |
| Stage1-vs-Stage4 |
1.87299999999668E-05 |
| Stage2-vs-Stage3 |
4.537200E-01 |
| Stage2-vs-Stage4 |
1.983230E-01 |
| Stage3-vs-Stage4 |
4.665800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4415999999583E-07 |
| Normal-vs-AfricanAmerican |
3.579200E-04 |
| Normal-vs-Asian |
9.711000E-01 |
| Caucasian-vs-AfricanAmerican |
6.220200E-01 |
| Caucasian-vs-Asian |
9.993600E-02 |
| AfricanAmerican-vs-Asian |
1.121030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.75049999945531E-07 |
| Normal-vs-Female |
4.28829999999936E-05 |
| Male-vs-Female |
6.105600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.250100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.4904999999964E-05 |
| Normal-vs-Age(61-80Yrs) |
1.01649999995068E-06 |
| Normal-vs-Age(81-100Yrs) |
2.736300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.961000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.414000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.647800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.451000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.910400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.423800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.075000E-01 |
| Normal-vs-Grade 2 |
5.142600E-03 |
| Normal-vs-Grade 3 |
1.04289999969254E-08 |
| Normal-vs-Grade 4 |
5.49920109449431E-11 |
| Grade 1-vs-Grade 2 |
8.824400E-02 |
| Grade 1-vs-Grade 3 |
7.380300E-04 |
| Grade 1-vs-Grade 4 |
1.82731999999186E-05 |
| Grade 2-vs-Grade 3 |
1.156950E-04 |
| Grade 2-vs-Grade 4 |
5.40309999963462E-07 |
| Grade 3-vs-Grade 4 |
7.817700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.205600E-02 |
| Normal-vs-ccB subtype |
2.86829999751603E-08 |
| ccA subtype-vs-ccB subtype |
1.55004999999875E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.23770000038226E-07 |
| Normal-vs-N1 |
1.200930E-03 |
| N0-vs-N1 |
5.601800E-01 |
|
|
